US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 276 actively recruiting studies with Virginia sites out of 276 registered in total. The busiest research areas in Virginia are Breast Cancer, Advanced Solid Tumor, Colorectal Cancer. Leading sponsors running trials in the state include Virginia Commonwealth University, University of Virginia, National Cancer Institute (NCI). By stage, Virginia trials break down as Phase 1 (75), Phase 2 (82), Phase 3 (85), Phase 4 (13).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
276
Recruiting Now
276
← Back to US Map
Top Conditions in Virginia
Breast Cancer (12)Advanced Solid Tumor (9)Colorectal Cancer (8)Solid Tumor (8)Prostate Cancer (8)Advanced Solid Tumors (7)Solid Tumors (6)Cancer (5)Ovarian Cancer (5)Obesity (5)Endometrial Cancer (4)Non-Small Cell Lung Cancer (4)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 276 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 276. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT06108050 Phase 1
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in...
Condition
Advanced Solid Tumor
Enrollment
177 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07315113 Phase 1
Recruiting
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Sma...
Condition
EGFR Mutation Positive Non-small Cell Lung Cancer
Enrollment
18 pts
Location
United States
Sponsor
Nuvectis Pharma, Inc.
View Trial →
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, China
Sponsor
Boston Scientific Corporation
View Trial →
NCT06625073 Phase 4
Recruiting
Randomized Trial of SGLT2i in Heart Transplant Recipients
Condition
Heart Transplant
Enrollment
200 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT05431088 Phase 2, Phase 3
Recruiting
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Condition
Sickle Cell Disease
Enrollment
389 pts
Location
United States, Brazil, India
Sponsor
Pfizer
View Trial →
NCT06835569 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tum...
Condition
Cancer
Enrollment
448 pts
Location
United States
Sponsor
Alterome Therapeutics, Inc.
View Trial →
NCT06007846 Phase 2, Phase 3
Recruiting
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Condition
Hepatocellular Carcinoma
Enrollment
12 pts
Location
United States
Sponsor
Inova Health Care Services
View Trial →
NCT06511141 N/A
Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Condition
Overactive Bladder
Enrollment
150 pts
Location
United States
Sponsor
Axonics, Inc.
View Trial →
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07207707 Phase 1
Recruiting
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Ad...
Condition
Solid Tumor Malignancies
Enrollment
78 pts
Location
United States
Sponsor
Kumquat Biosciences Inc.
View Trial →
NCT05223803 Phase 2
Recruiting
TERPS Trial for de Novo Oligometastic Prostate Cancer
Condition
Prostate Cancer
Enrollment
122 pts
Location
United States
Sponsor
University of Maryland, Baltim
View Trial →
NCT07221669 Phase 3
Recruiting
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety...
Condition
Muscular Atrophy, Spinal
Enrollment
30 pts
Location
United States, Australia, Brazil
Sponsor
Biogen
View Trial →
NCT06860594 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Th...
Condition
Astrocytoma, IDH-Mutant, Grade 2
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06850805 Phase 3
Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adole...
Condition
Chronic Rhinosinusitis Without Nasal Polyps
Enrollment
84 pts
Location
United States
Sponsor
Optinose US Inc.
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04922762 N/A
Recruiting
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals...
Condition
Peripheral Vascular Diseases
Enrollment
360 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT06867861 N/A
Recruiting
Effect of Fiber Supplementation on the Need for Medication With Gestational Diab...
Condition
Gestational Diabetes Mellitus (GDM)
Enrollment
110 pts
Location
United States
Sponsor
Eastern Virginia Medical Schoo
View Trial →
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
View Trial →
NCT04682483 N/A
Recruiting
Cardiogenic Shock Working Group Registry
Condition
Cardiogenic Shock
Enrollment
20,000 pts
Location
United States
Sponsor
Tufts Medical Center
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07201922 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in ...
Condition
Familial Pulmonary Fibrosis
Enrollment
80 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT06488001 Phase 2
Recruiting
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vom...
Condition
Postoperative Nausea and Vomiting
Enrollment
132 pts
Location
United States
Sponsor
United States Naval Medical Ce
View Trial →
NCT06810336 EARLY_Phase 1
Recruiting
Pain Control and Quality of Recovery After Intravenous Methadone Versus Intraven...
Condition
Brain Injury
Enrollment
40 pts
Location
United States
Sponsor
University of Virginia
View Trial →
Page 6 of 12 — 276 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology